1887

Abstract

SUMMARY

Human cells derived from both normal and neoplastic tissues can be infected by Mason-Pfizer monkey virus (MPMV) without accompanying cytopathology. Infection of cell cultures such as human rhabdomyosarcoma (A204) results in a persistently infected cell line which can be subcultured over 30 sequential culture passages without significant change in phenotypic properties according to reverse, transcriptase (RT), MPMV p27 antigen content, virus particle count and infectivity titre. Productive virus infections were established at relatively low virus particle (VP) input multiplicities (p.i.m.; about 0.06 VP/cell) in A204 cell cultures. At higher p.i.m. (about 600 to 6000 VP/cell) newly synthesized virus was detected within 4 days post infection. Although virus production was cumulative following primary infection, after subculture of infected cultures MPMV production was greater during active cell division. Using synchronization techniques, MPMV replication in persistently infected cultures was found to be cell cycle-dependent. The major internal antigen, p27, was synthesized in G and newly synthesized virus particles were released predominantly during mitosis and early G. Colcemid arrest of cells during mitosis inhibited subsequent MPMV release. Consequently, production of extracellular virus depends upon the progression of cells through the mitotic stage. These data, which provided a basic understanding of the virus-host relationship that occurs in primate cells productively infected with MPMV, were used as a guideline for isolating MPMV-like viruses from experimentally and naturally infected Rhesus monkeys.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-44-2-457
1979-08-01
2021-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/44/2/JV0440020457.html?itemId=/content/journal/jgv/10.1099/0022-1317-44-2-457&mimeType=html&fmt=ahah

References

  1. Ahmed M., Mayyasi S. A., Chopra H. C., Zelljadt I., Jensen E. M. 1971; Mason-Pfizer monkey virus M isolated from spontaneous mammary carcinoma of a female monkey. I. Detection of virus antigens by immunodiffusion, immunofluorescent and virus agglutination techniques. Journal of the National Cancer Institute 46:1325–1334
    [Google Scholar]
  2. Ahmed M., Schidlovsky G., Korol W., Vidrine G., Cicmanec J. 1974; Occurrence of Mason-Pfizer monkey virus in healthy rhesus monkeys. Cancer Research 34:3504–3508
    [Google Scholar]
  3. Ashkenazi-Ezra R., Ashkenazi I. E. 1976; Incorporation and uptake of thymidine and uridine by HeLa cells: effect of DNA extracts prepared from normal human fibroblasts. In vitro 12:442–449
    [Google Scholar]
  4. Benton C. V., Hodge H. M., Fine D. L. 1978; Comparative large scale propagation of retroviruses from Old World (Mason-Pfizer monkey virus) and New World (squirrel monkey virus) animals. In Vitro 14:192–200
    [Google Scholar]
  5. Benveniste R. E., Todaro G. J. 1977; Evolution of primate oncornaviruses: an endogenous virus from langurs (Prebytis spp.) with related virogene sequences in other Old World monkeys. Proceedings of the National Academy of Sciences of the United States of America 74:4557–4561
    [Google Scholar]
  6. Bogden A. E., Vidrine J. G., Esber H. J., Jensen E. M. 1978; Evidence for the horizontal transmission of infectious Mason-Pfizer monkey virus in the rhesus monkey. Proceedings of the American Society for Microbiology 78:240
    [Google Scholar]
  7. Bryant M. L., Sherr C. J., Sen A., Todaro G. J. 1978; Molecular diversity among five different endogenous primate retroviruses. Journal of Virology 28:300–313
    [Google Scholar]
  8. Cardiff R. D. 1973; Quantitation of mouse mammary tumor virus (MMTV) virions by radioimmunoassay. Journal of Immunology 111:1722–1729
    [Google Scholar]
  9. Chopra H. C., Mason M. M. 1970; A new virus in a spontaneous mammary tumor of a rhesus monkey. Cancer Research 30:2081–2086
    [Google Scholar]
  10. Colcher D. M., Schochetman G., Schlom J. 1975; Mason-Pfizer monkey virus (MPMV): a horizontally transmitted oncornavirus of rhesus monkeys. Proceedings of the American Association for Cancer Research 16:22
    [Google Scholar]
  11. Colcher D., Drohan W., Schlom J. 1976; Mason-Pfizer RNA genome: relationship to the RNA of morphologically similar isolates and other oncornaviruses. Journal of Virology 17:705–712
    [Google Scholar]
  12. Colcher D., Teramoto Y., Schlom J. 1977; An interspecies radioimmunoassay for the major structural proteins of primate type-D retroviruses. Proceedings of the National Academy of Sciences of the United States of America 74:5739–5743
    [Google Scholar]
  13. Devare S. G., Arthur L. O., Fine D. L., Stephenson J. R. 1978; Type D oncornaviruses: immunologic cross-reactivity between major structural proteins of New and Old World primate virus isolates. Journal of Virology 25:797–805
    [Google Scholar]
  14. Drohan W., Colcher D., Schochetman G., Schlom J. 1977; Distribution of Mason-Pfizer virus-specific sequences in the DNA of primates. Journal of Virology 23:36–43
    [Google Scholar]
  15. Fine D. L., Arthur L. O. 1978; Characterization of naturally-occurring humoral immune responses to type D retroviruses in primates. In Abstracts of the nth Meeting on Mammary Cancer in Experimental Animals and Man, 1978 p 98 Detroit, Michigan:
    [Google Scholar]
  16. Fine D. L., Schochetman O. 1978; Type D primate retroviruses: a Review. Cancer Research 38:3123–3139
    [Google Scholar]
  17. Fine D. L., Landon J. C., Kubicek M. T. 1971; Simian tumor virus isolate: demonstration of cytopathic effects in vitro. Science 74:420–421
    [Google Scholar]
  18. Fine D. L., Kingsbury E. W., Valerio M. G., Kubicek M. T., Landon J. C., Chopra H. C. 1972; Simian tumor virus proliferation in inoculated Macaco mulatto. Nature New Biology 238:191–192
    [Google Scholar]
  19. Fine D. L., Arthur L. O., Plowman J. K., Hillman E. A., Klein F. 1974; In vitro system for production of mouse mammary tumor virus. Applied Microbiology 28:1040–1046
    [Google Scholar]
  20. Fine D. L., Landon J. C., Pienta R. J., Kubicek M. J., Valerio M. J., Loeb W. F., Chopra H. C. 1975; Responses of infant rhesus monkeys to inoculation with Mason-Pfizer monkey virus materials. Journal of the National Cancer Institute 54:651–658
    [Google Scholar]
  21. Fine D. L., Devare S. G., Arthur L. O., Charman H. P., Stephenson J. R. 1978a; Type D retraviruses: occurrence of natural antibodies to Mason-Pfizer monkey virus in rhesus monkeys. Virology 86:567–571
    [Google Scholar]
  22. Fine D. L., Schochetman G., Arthur L. O., Gilden R. V. 1978b; Comparative studies on non-type C primate retraviruses: squirrel monkey virus (SMRV) from New World monkeys and Mason-Pfizer virus (MPMV) from Old World monkeys. In Advances in Comparative Leukaemia Research pp 242–244 Edited by Bentvelzen P., Yohn D. S. Amsterdam: Elsevier/North Holland Biomedical Press;
    [Google Scholar]
  23. Fischinger P. J., Tuttle-Fuller N., Huper G., Bolognesi D. P. 1975; Mitosis is required for production of murine leukaemia virus and production of murine leukemia virus and structural proteins during de novo infection. Journal of Virology 16:267–274
    [Google Scholar]
  24. Gey G. O., Coffman W. D., Kubicek M. T. 1952; Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Research 12:264
    [Google Scholar]
  25. Giard D., Aaronson S. A., Todaro G. J. 1973; In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. Journal of the National Cancer Institute 51:1417–1423
    [Google Scholar]
  26. Hackett A. J., Mith H. H. S., Springer E. L., Owens R. B., Nelson-Rees W. A., Riggs J. L., Gardner M. B. 1977; Two syngeneic cell lines from human breast tissue. The aneuploid mammary epithelial (HS578T) and the diploid myoepithelial (HS578BST) cell lines. Journal of the National Cancer Institute 58:1795–1806
    [Google Scholar]
  27. Harter D. N., Coward J. E. 1974; Sheep progressive pneumonia viruses: slow cytolytic agents with tumor virus properties: a Review. Texas Reports on Biology and Medicine 32:649–664
    [Google Scholar]
  28. Heberling R. L., Barker S. T., Kalter S. S., Smith G. C., Helmke R. J. 1977; Isolation of an oncornavirus from a squirrel monkey (Saimiri sciureus) lung culture. Science 195:289–291
    [Google Scholar]
  29. Hino S., Tronick S. R., Heberling R. L., Kalter S. S., Hellman A., Aaronson S. A. 1977; Endogenous New World primate retrovirus: interspecies antigenic determinants shared with the major structural protein of type D RNA viruses of Old World monkeys. Proceedings of the National Academy of Sciences of the United States of America 74:5734–5738
    [Google Scholar]
  30. Humphries E. H., Temin H. M. 1972; Cell cycle-dependent activation of Rous sarcoma virus-infected stationary chicken cells: avian leukosis virus group-specific antigens and ribonucleic acid. Journal of Virology 10:82–87
    [Google Scholar]
  31. Jensen E. M., Zelljadt L., Chopra H. C., Mason M. M. 1970; Isolation of a virus from a spontaneous mammary carcinoma of a rhesus monkey. Cancer Research 30:2388–2393
    [Google Scholar]
  32. Kawakami T. G., Sun L., McDowell T. S. 1977; Infectious primate type-C virus shed by healthy gibbons. Nature, London 268:448–450
    [Google Scholar]
  33. Klement V., Freedman M. H., McAllister R. M. 1971; Differences in susceptibility of human cells to mouse sarcoma virus. Journal of the National Cancer Institute 47:63–73
    [Google Scholar]
  34. Leong J. A., Levinson W., Bishop J. M. 1972; Synchronization of Rous sarcoma virus production in chick embryo cells. Virology 4 7:133–141
    [Google Scholar]
  35. Levy D., Deshayes L., Parodi A. L., Levy J. P., Stephenson J. R., Devare S. G., Gilden R. V. 1977; Bovine leukemia virus specific antibodies among French cattle. II. Radioimmunoassay with the major structural protein (BLV P24). International Journal of Cancer 20:543–550
    [Google Scholar]
  36. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
  37. McGuire T. C., Henson J. B. 1973; Equine infectious anemia-pathogenesis of persistent viral infection. In Perspectives in Virology vol VIII pp 229–247 Edited by Pollard M. Basel: Karger;
    [Google Scholar]
  38. Monroe J. H., Brandt P. M. 1970; Rapid semi-quantitative method for screening large numbers of virus samples by negative staining electron microscopy. Applied Microbiology 20:259–262
    [Google Scholar]
  39. Nelson-Rees W. A., Zhdanov V. M., Hawthorne P. K., Flandermeyer R. R. 1974; HeLa-like marker chromosomes and type-A variant glucose-6-phosphate dehydrogenase isoenzyme in human cell cultures producing Mason-Pfizer monkey virus-like particles. Journal of the National Cancer Institute 53:751–757
    [Google Scholar]
  40. Nelson-Rees W. A. 1977; Correspondence: Re: M. Lippman, G. Bolan and K. Huff, Three papers on hormones and breast cancer in vitro. Cancer Research 36:4595–4601 4602–4609, 4610–4618, 1976. Cancer Research 37, 3464–3465
    [Google Scholar]
  41. Nossik N., Priori E. S., Gonda M. A., Arthur L. O., Plowman J. K., Fine D. L. 1976; Replication and expression of Mason-Pfizer monkey virus in chronically infected primate cell cultures. In Vitro 12:319
    [Google Scholar]
  42. Panem S., Kirsten W. H. 1973; Release of mouse leukaemia-sarcoma virus from synchronized cells. Journal of the National Cancer Institute 50:563–565
    [Google Scholar]
  43. Panem S., Schauf V. 1974; Cell-cycle dependent appearance of murine leukaemia-sarcoma antigena. Journal of Virology 13:1169–1175
    [Google Scholar]
  44. Parks W. P., Gilden R. V., Bykovsky A. F., Muller G. G., Zhdanov V. M., Soloviev V. D., Scolnick E. M. 1973; Mason-Pfizer virus characterization: a similar virus in a human amniotic cell line. Journal of Virology 12:1540–1547
    [Google Scholar]
  45. Paskind M. P., Weinberg R. A., Baltimore D. 1975; Dependence of Moloney murine leukemia virus production on cell growth. Virology 67:242–248
    [Google Scholar]
  46. Rand K. H., Long C. W., Wei J. V., Gilden R. V. 1974; Plaque assay for the Mason-Pfizer monkey virus. Journal of the National Cancer Institute 53:449–452
    [Google Scholar]
  47. Rubin H., Fanshier L., Cornelius A., Hughes W. F. 1962; Tolerance and immunity in chickens after congenital and contact infection with an avian leukosis virus. Virology 17:143–156
    [Google Scholar]
  48. Schochetman G., Fine D. L. 1978; Natural distribution of squirrel monkey retrovirus proviral sequences in primate DNAs. Journal of General Virology 40:257–261
    [Google Scholar]
  49. Schochetman G., Fine D. L., Arthur L. O., Gilden R. V., Heberling R. L. 1977; Characterization of a retrovirus isolated from squirrel monkeys. Journal of Virology 23:384–393
    [Google Scholar]
  50. Todaro G. J., Benveniste R. E., Sherr C. J., Schlom J., Schidlovsky G., Stephenson J. R. 1978; Isolation and characterization of a new type D retrovirus from the asian primate, Presbytis obscurus (spectacled langur). Virology 84:189–194
    [Google Scholar]
  51. Walker D. H. 1964; The viral carrier state in animal cell cultures. In Progress in Medical Virology vol 6 pp 111–144 Edited by Melnick J. L. New York: Haufuer;
    [Google Scholar]
  52. Yeh J., Ahmed M., Lyles J., Larson D., Mayyasi S. A. 1975; Competition radioimmunoassay for Mason-Pfizer monkey virus: comparison with recent isolates. International Journal of Cancer 15:632–639
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-44-2-457
Loading
/content/journal/jgv/10.1099/0022-1317-44-2-457
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error